Literature DB >> 10583576

Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder.

P Middel1, B Hemmerlein, A Fayyazi, U Kaboth, H J Radzun.   

Abstract

AIMS: Sinus histiocytosis with massive lymphadenopathy (SHML) or Rosai-Dorfman disease is a rare histiocytic disorder of unknown origin. Immunophenotypically the histiocytes of SHML express intensively the S100 protein and in addition a panel of macrophage-associated antigens. Their exact relationship to either monocytes/macrophages or immune accessory dendritic cells is, however, still controversial. METHODS AND
RESULTS: In this report recurrent nodal and extranodal manifestations of SHML of a 70-year-old patient were analysed by differential phenotyping using a panel of monoclonal and polyclonal antibodies to macrophage and immune accessory dendritic cell related antigens and by applying nonradioactive in-situ hybridization.
CONCLUSIONS: We conclude that stimulation of monocytes/macrophages via macrophage colony stimulating factor (M-CSF) leading to immune suppressive macrophages represents a main mechanism for the pathogenesis of SHML. The study further provides evidence for the monocyte/macrophage but not dendritic cell differentiation of SHML histiocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583576     DOI: 10.1046/j.1365-2559.1999.00746.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

1.  Rosai-Dorfman disease with spinal cord compression: a diagnostic challenge.

Authors:  Sara Sciacca; Kostantinos Barkas; Lauren Heptinstall; Christopher McNamara; Rohit Shetty
Journal:  Eur Spine J       Date:  2014-11-15       Impact factor: 3.134

2.  The rosai dorfman syndrome-the report of a rare case.

Authors:  Snehalatha R; Senthilnathan P; Prathiba Ramani; Sherlin J Herald
Journal:  J Clin Diagn Res       Date:  2013-05-10

Review 3.  Extranodal Rosai-Dorfman disease of bone, subcutaneous tissue and paranasal sinus mucosa with a review of its pathogenesis.

Authors:  Angela J Yoon; May Parisien; Frieda Feldman; Francis Young-In Lee
Journal:  Skeletal Radiol       Date:  2005-08-11       Impact factor: 2.199

4.  Multifocal osseous involvement as the sole manifestation of Rosai-Dorfman disease.

Authors:  C Sundaram; G Uppin Shantveer; P Chandrashekar; V B N Prasad; M Umadevi
Journal:  Skeletal Radiol       Date:  2005-08-11       Impact factor: 2.199

5.  Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion.

Authors:  Archana Hinduja; L Giselle Aguilar; Thomas Steineke; David Nochlin; Joseph C Landolfi
Journal:  J Neurooncol       Date:  2008-11-20       Impact factor: 4.130

6.  Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease.

Authors:  Matthias S Matter; Michel Bihl; Darius Juskevicius; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2017-06-09       Impact factor: 4.064

7.  Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.

Authors:  Vignesh Shanmugam; Elizabeth Margolskee; Michael Kluk; Tamara Giorgadze; Attilio Orazi
Journal:  Head Neck Pathol       Date:  2016-02-27

8.  Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.

Authors:  Girish Venkataraman; Kenneth L McClain; Stefania Pittaluga; V Koneti Rao; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-04       Impact factor: 6.394

9.  Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations.

Authors:  Y Mehraein; M Wagner; K Remberger; L Füzesi; P Middel; S Kaptur; K Schmitt; E Meese
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

10.  [Extranodal Rosai Dorfman disease (sinus histiocytosis with massive lymphadenopathy). Report of 5 cases].

Authors:  W Hindermann; D Katenkamp
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.